INCE_HUMAN - dbPTM
INCE_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID INCE_HUMAN
UniProt AC Q9NQS7
Protein Name Inner centromere protein
Gene Name INCENP
Organism Homo sapiens (Human).
Sequence Length 918
Subcellular Localization Nucleus . Chromosome, centromere . Cytoplasm, cytoskeleton, spindle . Midbody . Chromosome, centromere, kinetochore . Colocalized at synaptonemal complex central element from zygotene up to late pachytene when it begins to relocalize to heterochromat
Protein Description Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Acts as a scaffold regulating CPC localization and activity. The C-terminus associates with AURKB or AURKC, the N-terminus associated with BIRC5/survivin and CDCA8/borealin tethers the CPC to the inner centromere, and the microtubule binding activity within the central SAH domain directs AURKB/C toward substrates near microtubules. [PubMed: 15316025]
Protein Sequence MGTTAPGPIHLLELCDQKLMEFLCNMDNKDLVWLEEIQEEAERMFTREFSKEPELMPKTPSQKNRRKKRRISYVQDENRDPIRRRLSRRKSRSSQLSSRRLRSKDSVEKLATVVGENGSVLRRVTRAAAAAAAATMALAAPSSPTPESPTMLTKKPEDNHTQCQLVPVVEIGISERQNAEQHVTQLMSTEPLPRTLSPTPASATAPTSQGIPTSDEESTPKKSKARILESITVSSLMATPQDPKGQGVGTGRSASKLRIAQVSPGPRDSPAFPDSPWRERVLAPILPDNFSTPTGSRTDSQSVRHSPIAPSSPSPQVLAQKYSLVAKQESVVRRASRRLAKKTAEEPAASGRIICHSYLERLLNVEVPQKVGSEQKEPPEEAEPVAAAEPEVPENNGNNSWPHNDTEIANSTPNPKPAASSPETPSAGQQEAKTDQADGPREPPQSARRKRSYKQAVSELDEEQHLEDEELQPPRSKTPSSPCPASKVVRPLRTFLHTVQRNQMLMTPTSAPRSVMKSFIKRNTPLRMDPKCSFVEKERQRLENLRRKEEAEQLRRQKVEEDKRRRLEEVKLKREERLRKVLQARERVEQMKEEKKKQIEQKFAQIDEKTEKAKEERLAEEKAKKKAAAKKMEEVEARRKQEEEARRLRWLQQEEEERRHQELLQKKKEEEQERLRKAAEAKRLAEQREQERREQERREQERREQERREQERREQERQLAEQERRREQERLQAERELQEREKALRLQKEQLQRELEEKKKKEEQQRLAERQLQEEQEKKAKEAAGASKALNVTVDVQSPACTSYQMTPQGHRAPPKINPDNYGMDLNSDDSTDDEAHPRKPIPTWARGTPLSQAIIHQYYHPPNLLELFGTILPLDLEDIFKKSKPRYHKRTSSAVWNSPPLQGARVPSSLAYSLKKH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MGTTAPGPIH
-----CCCCCCCCCH
20.6320068231
50PhosphorylationRMFTREFSKEPELMP
HHHHHHHHCCCCCCC
31.2120860994
51UbiquitinationMFTREFSKEPELMPK
HHHHHHHCCCCCCCC
80.6722817900
51 (in isoform 1)Ubiquitination-80.6721890473
51 (in isoform 2)Ubiquitination-80.6721890473
59PhosphorylationEPELMPKTPSQKNRR
CCCCCCCCCCHHCHH
23.4627273156
61PhosphorylationELMPKTPSQKNRRKK
CCCCCCCCHHCHHHH
60.0428450419
72PhosphorylationRRKKRRISYVQDENR
HHHHHHCCHHCCCCC
19.8930266825
73PhosphorylationRKKRRISYVQDENRD
HHHHHCCHHCCCCCH
10.3523927012
91PhosphorylationRRLSRRKSRSSQLSS
HHHHHHHHHHHHHHH
35.2725159151
93PhosphorylationLSRRKSRSSQLSSRR
HHHHHHHHHHHHHHH
29.5325159151
94PhosphorylationSRRKSRSSQLSSRRL
HHHHHHHHHHHHHHH
33.7526055452
97O-linked_GlycosylationKSRSSQLSSRRLRSK
HHHHHHHHHHHHCCH
17.7330379171
97PhosphorylationKSRSSQLSSRRLRSK
HHHHHHHHHHHHCCH
17.7329052541
98PhosphorylationSRSSQLSSRRLRSKD
HHHHHHHHHHHCCHH
29.9729052541
103PhosphorylationLSSRRLRSKDSVEKL
HHHHHHCCHHHHHHH
45.4617192257
104UbiquitinationSSRRLRSKDSVEKLA
HHHHHCCHHHHHHHH
47.8133845483
106PhosphorylationRRLRSKDSVEKLATV
HHHCCHHHHHHHHHH
35.5928985074
109UbiquitinationRSKDSVEKLATVVGE
CCHHHHHHHHHHHCC
41.0629967540
112PhosphorylationDSVEKLATVVGENGS
HHHHHHHHHHCCCCH
26.5920860994
119PhosphorylationTVVGENGSVLRRVTR
HHHCCCCHHHHHHHH
29.5630266825
135PhosphorylationAAAAAAATMALAAPS
HHHHHHHHHHHHCCC
9.7629255136
142PhosphorylationTMALAAPSSPTPESP
HHHHHCCCCCCCCCC
44.1930266825
143PhosphorylationMALAAPSSPTPESPT
HHHHCCCCCCCCCCC
31.5629255136
145PhosphorylationLAAPSSPTPESPTML
HHCCCCCCCCCCCCC
41.4530266825
148PhosphorylationPSSPTPESPTMLTKK
CCCCCCCCCCCCCCC
27.2028176443
150PhosphorylationSPTPESPTMLTKKPE
CCCCCCCCCCCCCCC
33.8130266825
153PhosphorylationPESPTMLTKKPEDNH
CCCCCCCCCCCCCCC
26.6326055452
184PhosphorylationQNAEQHVTQLMSTEP
CCHHHHHHHHHCCCC
17.5426074081
188PhosphorylationQHVTQLMSTEPLPRT
HHHHHHHCCCCCCCC
37.9126074081
189PhosphorylationHVTQLMSTEPLPRTL
HHHHHHCCCCCCCCC
27.8826074081
195PhosphorylationSTEPLPRTLSPTPAS
CCCCCCCCCCCCCCC
29.6423927012
197PhosphorylationEPLPRTLSPTPASAT
CCCCCCCCCCCCCCC
26.5625159151
199PhosphorylationLPRTLSPTPASATAP
CCCCCCCCCCCCCCC
28.2823927012
202PhosphorylationTLSPTPASATAPTSQ
CCCCCCCCCCCCCCC
27.6230266825
204PhosphorylationSPTPASATAPTSQGI
CCCCCCCCCCCCCCC
30.5823927012
207PhosphorylationPASATAPTSQGIPTS
CCCCCCCCCCCCCCC
31.0830266825
208PhosphorylationASATAPTSQGIPTSD
CCCCCCCCCCCCCCC
25.9230266825
213PhosphorylationPTSQGIPTSDEESTP
CCCCCCCCCCCCCCC
47.0625159151
214PhosphorylationTSQGIPTSDEESTPK
CCCCCCCCCCCCCCC
37.3625159151
218PhosphorylationIPTSDEESTPKKSKA
CCCCCCCCCCCHHHH
48.2225159151
219PhosphorylationPTSDEESTPKKSKAR
CCCCCCCCCCHHHHH
42.2723927012
223PhosphorylationEESTPKKSKARILES
CCCCCCHHHHHHHHH
37.3630576142
230PhosphorylationSKARILESITVSSLM
HHHHHHHHCCHHHHH
21.8026055452
232PhosphorylationARILESITVSSLMAT
HHHHHHCCHHHHHCC
24.5021712546
234PhosphorylationILESITVSSLMATPQ
HHHHCCHHHHHCCCC
14.7626055452
235PhosphorylationLESITVSSLMATPQD
HHHCCHHHHHCCCCC
20.1629255136
239PhosphorylationTVSSLMATPQDPKGQ
CHHHHHCCCCCCCCC
13.9129255136
250PhosphorylationPKGQGVGTGRSASKL
CCCCCCCCCCCCCCE
27.3224732914
253PhosphorylationQGVGTGRSASKLRIA
CCCCCCCCCCCEEEE
37.9325849741
255PhosphorylationVGTGRSASKLRIAQV
CCCCCCCCCEEEEEE
33.2121712546
263PhosphorylationKLRIAQVSPGPRDSP
CEEEEEECCCCCCCC
16.4429255136
269PhosphorylationVSPGPRDSPAFPDSP
ECCCCCCCCCCCCCC
21.2925159151
275PhosphorylationDSPAFPDSPWRERVL
CCCCCCCCCHHHHCC
26.9722167270
291PhosphorylationPILPDNFSTPTGSRT
CCCCCCCCCCCCCCC
39.4729255136
292PhosphorylationILPDNFSTPTGSRTD
CCCCCCCCCCCCCCC
22.2629255136
294PhosphorylationPDNFSTPTGSRTDSQ
CCCCCCCCCCCCCCC
48.1330266825
296PhosphorylationNFSTPTGSRTDSQSV
CCCCCCCCCCCCCCC
34.1930266825
298PhosphorylationSTPTGSRTDSQSVRH
CCCCCCCCCCCCCCC
41.5223927012
300PhosphorylationPTGSRTDSQSVRHSP
CCCCCCCCCCCCCCC
24.6023401153
302PhosphorylationGSRTDSQSVRHSPIA
CCCCCCCCCCCCCCC
25.6830278072
306PhosphorylationDSQSVRHSPIAPSSP
CCCCCCCCCCCCCCC
13.8729255136
311PhosphorylationRHSPIAPSSPSPQVL
CCCCCCCCCCCHHHH
45.9529255136
312PhosphorylationHSPIAPSSPSPQVLA
CCCCCCCCCCHHHHH
28.4729255136
314PhosphorylationPIAPSSPSPQVLAQK
CCCCCCCCHHHHHHH
29.8829255136
321AcetylationSPQVLAQKYSLVAKQ
CHHHHHHHHHHHHHH
31.0625953088
321UbiquitinationSPQVLAQKYSLVAKQ
CHHHHHHHHHHHHHH
31.0622817900
321 (in isoform 1)Ubiquitination-31.0621890473
321 (in isoform 2)Ubiquitination-31.0621890473
322PhosphorylationPQVLAQKYSLVAKQE
HHHHHHHHHHHHHHH
8.6524732914
323PhosphorylationQVLAQKYSLVAKQES
HHHHHHHHHHHHHHH
24.3324732914
327SumoylationQKYSLVAKQESVVRR
HHHHHHHHHHHHHHH
47.31-
327AcetylationQKYSLVAKQESVVRR
HHHHHHHHHHHHHHH
47.3125953088
327SumoylationQKYSLVAKQESVVRR
HHHHHHHHHHHHHHH
47.31-
327UbiquitinationQKYSLVAKQESVVRR
HHHHHHHHHHHHHHH
47.3133845483
330PhosphorylationSLVAKQESVVRRASR
HHHHHHHHHHHHHHH
24.3421712546
336PhosphorylationESVVRRASRRLAKKT
HHHHHHHHHHHHHHH
19.0022817900
341MethylationRASRRLAKKTAEEPA
HHHHHHHHHHCCCCC
56.07116253813
343PhosphorylationSRRLAKKTAEEPAAS
HHHHHHHHCCCCCCC
38.30-
350PhosphorylationTAEEPAASGRIICHS
HCCCCCCCCCEEEHH
30.6120860994
357PhosphorylationSGRIICHSYLERLLN
CCCEEEHHHHHHHHC
27.3125159151
358PhosphorylationGRIICHSYLERLLNV
CCEEEHHHHHHHHCC
6.7429396449
370UbiquitinationLNVEVPQKVGSEQKE
HCCCCCCCCCCCCCC
42.3633845483
373PhosphorylationEVPQKVGSEQKEPPE
CCCCCCCCCCCCCCH
39.5820860994
400PhosphorylationPENNGNNSWPHNDTE
CCCCCCCCCCCCCCH
46.0817192257
406PhosphorylationNSWPHNDTEIANSTP
CCCCCCCCHHCCCCC
34.3117192257
411PhosphorylationNDTEIANSTPNPKPA
CCCHHCCCCCCCCCC
35.9017192257
412PhosphorylationDTEIANSTPNPKPAA
CCHHCCCCCCCCCCC
27.2225159151
420PhosphorylationPNPKPAASSPETPSA
CCCCCCCCCCCCCCC
48.8325159151
421PhosphorylationNPKPAASSPETPSAG
CCCCCCCCCCCCCCC
23.2529255136
424PhosphorylationPAASSPETPSAGQQE
CCCCCCCCCCCCCCC
26.4029255136
426PhosphorylationASSPETPSAGQQEAK
CCCCCCCCCCCCCCC
53.0729255136
434PhosphorylationAGQQEAKTDQADGPR
CCCCCCCCCCCCCCC
40.1523186163
446PhosphorylationGPREPPQSARRKRSY
CCCCCCHHHHHHHHH
29.5325159151
452PhosphorylationQSARRKRSYKQAVSE
HHHHHHHHHHHHHHH
39.4523401153
453PhosphorylationSARRKRSYKQAVSEL
HHHHHHHHHHHHHHC
15.9127134283
454AcetylationARRKRSYKQAVSELD
HHHHHHHHHHHHHCC
32.7825953088
458PhosphorylationRSYKQAVSELDEEQH
HHHHHHHHHCCHHHC
35.1421082442
476PhosphorylationEELQPPRSKTPSSPC
CCCCCCCCCCCCCCC
46.8125159151
478PhosphorylationLQPPRSKTPSSPCPA
CCCCCCCCCCCCCCH
29.6523401153
480PhosphorylationPPRSKTPSSPCPASK
CCCCCCCCCCCCHHH
52.7430266825
481PhosphorylationPRSKTPSSPCPASKV
CCCCCCCCCCCHHHH
31.5523401153
486PhosphorylationPSSPCPASKVVRPLR
CCCCCCHHHHHHCHH
15.8922115753
487AcetylationSSPCPASKVVRPLRT
CCCCCHHHHHHCHHH
47.027308167
494PhosphorylationKVVRPLRTFLHTVQR
HHHHCHHHHHHHHHH
37.93-
498PhosphorylationPLRTFLHTVQRNQML
CHHHHHHHHHHCCCC
22.0823312004
507PhosphorylationQRNQMLMTPTSAPRS
HHCCCCCCCCCCCHH
21.3226055452
509PhosphorylationNQMLMTPTSAPRSVM
CCCCCCCCCCCHHHH
28.4926055452
510PhosphorylationQMLMTPTSAPRSVMK
CCCCCCCCCCHHHHH
37.1626055452
514PhosphorylationTPTSAPRSVMKSFIK
CCCCCCHHHHHHHHH
26.0418669648
517AcetylationSAPRSVMKSFIKRNT
CCCHHHHHHHHHCCC
39.8125953088
518PhosphorylationAPRSVMKSFIKRNTP
CCHHHHHHHHHCCCC
17.7020860994
521UbiquitinationSVMKSFIKRNTPLRM
HHHHHHHHCCCCCCC
37.2732015554
524PhosphorylationKSFIKRNTPLRMDPK
HHHHHCCCCCCCCCC
27.9430576142
548UbiquitinationRLENLRRKEEAEQLR
HHHHHHHHHHHHHHH
54.1729967540
592UbiquitinationRERVEQMKEEKKKQI
HHHHHHHHHHHHHHH
63.5223000965
593UbiquitinationERVEQMKEEKKKQIE
HHHHHHHHHHHHHHH
70.4823000965
596UbiquitinationEQMKEEKKKQIEQKF
HHHHHHHHHHHHHHH
53.8723000965
597UbiquitinationQMKEEKKKQIEQKFA
HHHHHHHHHHHHHHH
68.5223000965
598UbiquitinationMKEEKKKQIEQKFAQ
HHHHHHHHHHHHHHH
54.0221890473
598 (in isoform 2)Ubiquitination-54.0221890473
602AcetylationKKKQIEQKFAQIDEK
HHHHHHHHHHHHHHH
29.8520167786
602UbiquitinationKKKQIEQKFAQIDEK
HHHHHHHHHHHHHHH
29.8523000965
602 (in isoform 1)Ubiquitination-29.8521890473
609AcetylationKFAQIDEKTEKAKEE
HHHHHHHHHHHHHHH
59.2320167786
610PhosphorylationFAQIDEKTEKAKEER
HHHHHHHHHHHHHHH
40.4420068231
630"N6,N6-dimethyllysine"AKKKAAAKKMEEVEA
HHHHHHHHHHHHHHH
48.18-
630AcetylationAKKKAAAKKMEEVEA
HHHHHHHHHHHHHHH
48.1812437563
630MethylationAKKKAAAKKMEEVEA
HHHHHHHHHHHHHHH
48.18-
631"N6,N6-dimethyllysine"KKKAAAKKMEEVEAR
HHHHHHHHHHHHHHH
46.98-
631AcetylationKKKAAAKKMEEVEAR
HHHHHHHHHHHHHHH
46.9812437571
631MethylationKKKAAAKKMEEVEAR
HHHHHHHHHHHHHHH
46.98-
744UbiquitinationLQEREKALRLQKEQL
HHHHHHHHHHHHHHH
9.2229967540
748UbiquitinationEKALRLQKEQLQREL
HHHHHHHHHHHHHHH
52.6129967540
793PhosphorylationASKALNVTVDVQSPA
CCHHCCCEEEECCCC
15.2024732914
798PhosphorylationNVTVDVQSPACTSYQ
CCEEEECCCCCCCEE
17.8225159151
802PhosphorylationDVQSPACTSYQMTPQ
EECCCCCCCEEECCC
32.3524732914
803PhosphorylationVQSPACTSYQMTPQG
ECCCCCCCEEECCCC
17.1625159151
804PhosphorylationQSPACTSYQMTPQGH
CCCCCCCEEECCCCC
5.5524732914
807PhosphorylationACTSYQMTPQGHRAP
CCCCEEECCCCCCCC
9.2725159151
808PhosphorylationCTSYQMTPQGHRAPP
CCCEEECCCCCCCCC
32.5818669648
822PhosphorylationPKINPDNYGMDLNSD
CCCCCCCCCCCCCCC
22.6223927012
828PhosphorylationNYGMDLNSDDSTDDE
CCCCCCCCCCCCCCC
50.5223927012
831PhosphorylationMDLNSDDSTDDEAHP
CCCCCCCCCCCCCCC
38.4323927012
832PhosphorylationDLNSDDSTDDEAHPR
CCCCCCCCCCCCCCC
55.2323927012
833PhosphorylationLNSDDSTDDEAHPRK
CCCCCCCCCCCCCCC
56.5622067460
836PhosphorylationDDSTDDEAHPRKPIP
CCCCCCCCCCCCCCC
25.6122067460
837PhosphorylationDSTDDEAHPRKPIPT
CCCCCCCCCCCCCCC
22.2022067460
844PhosphorylationHPRKPIPTWARGTPL
CCCCCCCCCCCCCCH
32.2620068231
852PhosphorylationWARGTPLSQAIIHQY
CCCCCCHHHHHHHHH
20.8325332170
859PhosphorylationSQAIIHQYYHPPNLL
HHHHHHHHCCCCCHH
6.9225332170
887 (in isoform 2)Methylation-50.34-
892PhosphorylationKPRYHKRTSSAVWNS
CCCCCCCCCCCCCCC
31.6623401153
893PhosphorylationPRYHKRTSSAVWNSP
CCCCCCCCCCCCCCC
21.9730266825
894PhosphorylationRYHKRTSSAVWNSPP
CCCCCCCCCCCCCCC
26.6522024163
897PhosphorylationKRTSSAVWNSPPLQG
CCCCCCCCCCCCCCC
10.1712925766
898PhosphorylationRTSSAVWNSPPLQGA
CCCCCCCCCCCCCCC
37.7322067460
899PhosphorylationTSSAVWNSPPLQGAR
CCCCCCCCCCCCCCC
16.5125159151
904PhosphorylationWNSPPLQGARVPSSL
CCCCCCCCCCCCHHH
24.0422067460
909PhosphorylationLQGARVPSSLAYSLK
CCCCCCCHHHHHHHH
34.8218691976
910O-linked_GlycosylationQGARVPSSLAYSLKK
CCCCCCHHHHHHHHC
15.7930379171
910PhosphorylationQGARVPSSLAYSLKK
CCCCCCHHHHHHHHC
15.7918669648
913PhosphorylationRVPSSLAYSLKKH--
CCCHHHHHHHHCC--
21.5925159151
914PhosphorylationVPSSLAYSLKKH---
CCHHHHHHHHCC---
28.2723401153
916AcetylationSSLAYSLKKH-----
HHHHHHHHCC-----
42.7525953088
916MethylationSSLAYSLKKH-----
HHHHHHHHCC-----
42.75115971431
917MethylationSLAYSLKKH------
HHHHHHHCC------
60.90115971435
919PhosphorylationAYSLKKH--------
HHHHHCC--------
22067460

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
59TPhosphorylationKinaseAURKBQ96GD4
GPS
72SPhosphorylationKinaseAURKBQ96GD4
GPS
494TPhosphorylationKinaseAURKBQ96GD4
GPS
518SPhosphorylationKinaseAURKBQ96GD4
GPS
892TPhosphorylationKinaseAURBQ96GD4
PSP
892TPhosphorylationKinaseAURCQ9UQB9
PSP
893SPhosphorylationKinaseAURBQ96GD4
PSP
893SPhosphorylationKinaseAURCQ9UQB9
PSP
894SPhosphorylationKinaseAURBQ96GD4
PSP
894SPhosphorylationKinaseAURCQ9UQB9
PSP
894SPhosphorylationKinaseLATS1O95835
PSP
894SPhosphorylationKinaseLATS2Q9NRM7
PSP
897TPhosphorylationKinaseAURKBQ96GD4
PhosphoELM
898SPhosphorylationKinaseAURKBQ96GD4
PhosphoELM
899SPhosphorylationKinaseAURKBQ96GD4
PhosphoELM
899SPhosphorylationKinaseAURKBQ96GD4
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of INCE_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of INCE_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BIRC5_HUMANBIRC5physical
19951914
BOREA_HUMANCDCA8physical
19951914
AURKB_HUMANAURKBphysical
19951914
AURKA_HUMANAURKAphysical
18773538
AURKB_HUMANAURKBphysical
18773538
AURKA_HUMANAURKAphysical
11050385
AURKB_HUMANAURKBphysical
11050385
BIRC5_HUMANBIRC5physical
16239925
AURKB_HUMANAURKBphysical
16239925
BOREA_HUMANCDCA8physical
16239925
AURKB_HUMANAURKBphysical
12925766
CBX5_HUMANCBX5physical
20562864
AURKB_HUMANAURKBphysical
20562864
BOREA_HUMANCDCA8physical
17956729
BIRC5_HUMANBIRC5physical
17956729
AURKB_HUMANAURKBphysical
17956729
BIRC5_HUMANBIRC5physical
16571674
BOREA_HUMANCDCA8physical
16571674
AURKB_HUMANAURKBphysical
16571674
AURKC_HUMANAURKCphysical
15316025
AURKB_HUMANAURKBphysical
15316025

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of INCE_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197; THR-199; THR-213;SER-214; THR-239; SER-263; SER-269; SER-275; SER-306; SER-314;TYR-822; SER-828; SER-831; THR-832; SER-899 AND SER-914, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142; SER-143; THR-145;SER-148; THR-150; SER-197; THR-213; SER-214; SER-263; SER-291;THR-298; SER-311; SER-314; SER-421; SER-828; SER-831; THR-832; THR-892AND SER-899, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-195; THR-213; SER-214;SER-218; THR-219; SER-263; THR-292; SER-421 AND THR-424, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119; THR-145; SER-148;SER-197; THR-213; SER-218; SER-230; THR-239; SER-263; SER-269;SER-275; THR-292; SER-296; THR-298; SER-306; SER-312; SER-314;SER-446; THR-507; THR-509; SER-510; SER-514; SER-828; SER-831;THR-832; SER-893; SER-894; SER-899 AND SER-914, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72; TYR-73; SER-91;SER-93; SER-94; SER-103; SER-143; SER-148; SER-214; SER-218; THR-239;SER-263; SER-269; SER-275; THR-292; SER-296; SER-306; SER-312;SER-400; THR-406; SER-411; SER-420; SER-421; THR-424; SER-446;SER-458; SER-476; THR-478; SER-480; SER-481; SER-893; SER-894 ANDSER-899, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72; SER-263; SER-269;SER-275; THR-292 AND SER-296, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-72; TYR-73;SER-106; SER-119; THR-195; SER-197; THR-199; SER-214; SER-230;SER-235; THR-239; SER-263; SER-269; SER-275; THR-292; SER-306;SER-350; SER-373; THR-412; SER-420; SER-421; THR-424; SER-446;SER-481; THR-507; THR-509; SER-510; THR-793; SER-798 AND SER-899, ANDMASS SPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-73; SER-119; SER-142;SER-143; SER-148; SER-197; THR-199; THR-213; SER-214; THR-219;SER-230; THR-239; SER-263; SER-269; SER-275; SER-291; THR-292;THR-294; SER-296; SER-306; SER-312; SER-314; SER-421; THR-424;SER-481; SER-828; SER-831; THR-832; THR-892; SER-893; SER-894 ANDSER-899, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263; SER-269; SER-275;THR-298; SER-312; SER-314 AND SER-421, AND MASS SPECTROMETRY.
"Exploring the functional interactions between Aurora B, INCENP, andsurvivin in mitosis.";
Honda R., Korner R., Nigg E.A.;
Mol. Biol. Cell 14:3325-3341(2003).
Cited for: IDENTIFICATION IN THE CPC COMPLEX, FUNCTION OF THE CPC COMPLEX,INDUCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT THR-892;SER-893 AND SER-894.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-292, AND MASSSPECTROMETRY.

TOP